Screening for Primary Open-Angle Glaucoma: US Preventive Services Task Force Recommendation Statement

Carol M. Mangione; Michael J. Barry; Wanda K. Nicholson; Michael Cabana; David Chelmow; Tumaini Rucker Coker; Esa M. Davis; Katrina E. Donahue; John W. Epling; Carlos Roberto Jaén; Alex H. Krist; Martha Kubik; Li Li; Gbenga Ogedegbe; Lori Pbert; John M. Ruiz; Melissa A. Simon; James Stevermer; John B. Wong

doi:10.1001/jama.2022.7013

Screening for Primary Open-Angle Glaucoma: US Preventive Services Task Force Recommendation Statement

Carol M. Mangione, Michael J. Barry, Wanda K. Nicholson, Michael Cabana, David Chelmow, Tumaini Rucker Coker, Esa M. Davis, Katrina E. Donahue, John W. Epling, Carlos Roberto Jaén, Alex H. Krist, Martha Kubik, Li Li, Gbenga Ogedegbe, Lori Pbert, John M. Ruiz, Melissa A. Simon, James Stevermer, John B. Wong

Pediatrics

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Abstract

Importance: Glaucoma affects an estimated 2.7 million people in the US. It is the second-leading cause of irreversible blindness in the US and the leading cause of blindness in Black and Hispanic/Latino persons. Objective: To update its 2013 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for glaucoma in adults. Population: Adults 40 years or older who present in primary care and do not have signs or symptoms of open-angle glaucoma. Evidence Assessment: The USPSTF concludes that the evidence is insufficient to assess the balance of benefits and harms of screening for glaucoma in adults. The benefits and harms of screening for glaucoma in adults are uncertain. More research is needed. Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for primary open-angle glaucoma in adults. (I statement).

Original language	English (US)
Pages (from-to)	1992-1997
Number of pages	6
Journal	JAMA - Journal of the American Medical Association
Volume	327
Issue number	20
DOIs	https://doi.org/10.1001/jama.2022.7013
State	Published - May 24 2022

ASJC Scopus subject areas

General Medicine

Access to Document

10.1001/jama.2022.7013

Cite this

Mangione, C. M., Barry, M. J., Nicholson, W. K., Cabana, M., Chelmow, D., Coker, T. R., Davis, E. M., Donahue, K. E., Epling, J. W., Jaén, C. R., Krist, A. H., Kubik, M., Li, L., Ogedegbe, G., Pbert, L., Ruiz, J. M., Simon, M. A., Stevermer, J., & Wong, J. B. (2022). Screening for Primary Open-Angle Glaucoma: US Preventive Services Task Force Recommendation Statement. JAMA - Journal of the American Medical Association, 327(20), 1992-1997. https://doi.org/10.1001/jama.2022.7013

Mangione, CM, Barry, MJ, Nicholson, WK, Cabana, M, Chelmow, D, Coker, TR, Davis, EM, Donahue, KE, Epling, JW, Jaén, CR, Krist, AH, Kubik, M, Li, L, Ogedegbe, G, Pbert, L, Ruiz, JM, Simon, MA, Stevermer, J & Wong, JB 2022, 'Screening for Primary Open-Angle Glaucoma: US Preventive Services Task Force Recommendation Statement', JAMA - Journal of the American Medical Association, vol. 327, no. 20, pp. 1992-1997. https://doi.org/10.1001/jama.2022.7013

@article{4613621d0f49492699024caf04572f28,

title = "Screening for Primary Open-Angle Glaucoma: US Preventive Services Task Force Recommendation Statement",

abstract = "Importance: Glaucoma affects an estimated 2.7 million people in the US. It is the second-leading cause of irreversible blindness in the US and the leading cause of blindness in Black and Hispanic/Latino persons. Objective: To update its 2013 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for glaucoma in adults. Population: Adults 40 years or older who present in primary care and do not have signs or symptoms of open-angle glaucoma. Evidence Assessment: The USPSTF concludes that the evidence is insufficient to assess the balance of benefits and harms of screening for glaucoma in adults. The benefits and harms of screening for glaucoma in adults are uncertain. More research is needed. Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for primary open-angle glaucoma in adults. (I statement).",

author = "Mangione, {Carol M.} and Barry, {Michael J.} and Nicholson, {Wanda K.} and Michael Cabana and David Chelmow and Coker, {Tumaini Rucker} and Davis, {Esa M.} and Donahue, {Katrina E.} and Epling, {John W.} and Ja{\'e}n, {Carlos Roberto} and Krist, {Alex H.} and Martha Kubik and Li Li and Gbenga Ogedegbe and Lori Pbert and Ruiz, {John M.} and Simon, {Melissa A.} and James Stevermer and Wong, {John B.}",

year = "2022",

month = may,

day = "24",

doi = "10.1001/jama.2022.7013",

language = "English (US)",

volume = "327",

pages = "1992--1997",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "20",

}

TY - JOUR

T1 - Screening for Primary Open-Angle Glaucoma

T2 - US Preventive Services Task Force Recommendation Statement

AU - Mangione, Carol M.

AU - Barry, Michael J.

AU - Nicholson, Wanda K.

AU - Cabana, Michael

AU - Chelmow, David

AU - Coker, Tumaini Rucker

AU - Davis, Esa M.

AU - Donahue, Katrina E.

AU - Epling, John W.

AU - Jaén, Carlos Roberto

AU - Krist, Alex H.

AU - Kubik, Martha

AU - Li, Li

AU - Ogedegbe, Gbenga

AU - Pbert, Lori

AU - Ruiz, John M.

AU - Simon, Melissa A.

AU - Stevermer, James

AU - Wong, John B.

PY - 2022/5/24

Y1 - 2022/5/24

N2 - Importance: Glaucoma affects an estimated 2.7 million people in the US. It is the second-leading cause of irreversible blindness in the US and the leading cause of blindness in Black and Hispanic/Latino persons. Objective: To update its 2013 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for glaucoma in adults. Population: Adults 40 years or older who present in primary care and do not have signs or symptoms of open-angle glaucoma. Evidence Assessment: The USPSTF concludes that the evidence is insufficient to assess the balance of benefits and harms of screening for glaucoma in adults. The benefits and harms of screening for glaucoma in adults are uncertain. More research is needed. Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for primary open-angle glaucoma in adults. (I statement).

AB - Importance: Glaucoma affects an estimated 2.7 million people in the US. It is the second-leading cause of irreversible blindness in the US and the leading cause of blindness in Black and Hispanic/Latino persons. Objective: To update its 2013 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for glaucoma in adults. Population: Adults 40 years or older who present in primary care and do not have signs or symptoms of open-angle glaucoma. Evidence Assessment: The USPSTF concludes that the evidence is insufficient to assess the balance of benefits and harms of screening for glaucoma in adults. The benefits and harms of screening for glaucoma in adults are uncertain. More research is needed. Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for primary open-angle glaucoma in adults. (I statement).

UR - http://www.scopus.com/inward/record.url?scp=85130717757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85130717757&partnerID=8YFLogxK

U2 - 10.1001/jama.2022.7013

DO - 10.1001/jama.2022.7013

M3 - Article

C2 - 35608574

AN - SCOPUS:85130717757

SN - 0098-7484

VL - 327

SP - 1992

EP - 1997

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 20

ER -

Screening for Primary Open-Angle Glaucoma: US Preventive Services Task Force Recommendation Statement

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this